194 related articles for article (PubMed ID: 17971213)
21. Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines.
Paulsson KM; Wang P; Anderson PO; Chen S; Pettersson RF; Li S
Int Immunol; 2001 Aug; 13(8):1063-73. PubMed ID: 11470776
[TBL] [Abstract][Full Text] [Related]
22. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
[TBL] [Abstract][Full Text] [Related]
23. RNA interference of human papillomavirus type 16 E7 increases HLA class I antigen expression in HaCaT-E7 cells.
Deng XM; Li W; Zhang X; Wang CX; Dong ZG; Zhang X; Zheng GX; Zhang XH; Zheng N; Wang LL; Du LT; Wang S
Int J Gynecol Cancer; 2011 Jan; 21(1):28-34. PubMed ID: 21330828
[TBL] [Abstract][Full Text] [Related]
24. The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region.
Krawczyk E; Suprynowicz FA; Hebert JD; Kamonjoh CM; Schlegel R
J Virol; 2011 Nov; 85(21):10968-75. PubMed ID: 21849434
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
26. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.
Suprynowicz FA; Disbrow GL; Krawczyk E; Simic V; Lantzky K; Schlegel R
Oncogene; 2008 Feb; 27(8):1071-8. PubMed ID: 17704805
[TBL] [Abstract][Full Text] [Related]
27. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells.
Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V
Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629
[TBL] [Abstract][Full Text] [Related]
28. Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach.
Kumar A; Yadav IS; Hussain S; Das BC; Bharadwaj M
Biologicals; 2015 Sep; 43(5):344-8. PubMed ID: 26212000
[TBL] [Abstract][Full Text] [Related]
29. Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.
Martayan A; Fraioli R; Giorda E; Setini A; Ciccarelli G; Delfino L; Ferrara GB; Giacomini P
Br J Cancer; 1999 May; 80(5-6):639-49. PubMed ID: 10360639
[TBL] [Abstract][Full Text] [Related]
30. SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.
Alam A; Taye N; Patel S; Thube M; Mullick J; Shah VK; Pant R; Roychowdhury T; Banerjee N; Chatterjee S; Bhattacharya R; Roy R; Mukhopadhyay A; Mogare D; Chattopadhyay S
Neoplasia; 2019 Oct; 21(10):945-962. PubMed ID: 31422285
[TBL] [Abstract][Full Text] [Related]
31. HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7.
Liao S; Deng D; Hu X; Wang W; Li L; Li W; Zhou J; Xu G; Meng L; Wang S; Ma D
Int J Mol Med; 2013 Jan; 31(1):120-8. PubMed ID: 23128250
[TBL] [Abstract][Full Text] [Related]
32. HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic.
Belleudi F; Leone L; Purpura V; Cannella F; Scrofani C; Torrisi MR
Oncogene; 2011 Dec; 30(50):4963-76. PubMed ID: 21625213
[TBL] [Abstract][Full Text] [Related]
33. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.
Liu C; Lin J; Li L; Zhang Y; Chen W; Cao Z; Zuo H; Chen C; Kee K
Sci Rep; 2015 Jan; 5():7653. PubMed ID: 25563170
[TBL] [Abstract][Full Text] [Related]
34. Lectin-deficient calnexin is capable of binding class I histocompatibility molecules in vivo and preventing their degradation.
Leach MR; Williams DB
J Biol Chem; 2004 Mar; 279(10):9072-9. PubMed ID: 14699098
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.
Nilson LA; Gottlieb RL; Polack GW; DiMaio D
J Virol; 1995 Sep; 69(9):5869-74. PubMed ID: 7543592
[TBL] [Abstract][Full Text] [Related]
36. HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter.
Li H; Ou X; Xiong J; Wang T
Biochem Biophys Res Commun; 2006 Nov; 349(4):1315-21. PubMed ID: 16979588
[TBL] [Abstract][Full Text] [Related]
37. Identification of membrane proteins differentially expressed in human papillomavirus type 16 E5-transfected human keratinocytes by nanoelectrospray ionization mass spectrometry.
Leykauf K; Salek M; Schlüter H; Lehmann WD; Alonso A
J Gen Virol; 2004 Jun; 85(Pt 6):1427-1431. PubMed ID: 15166425
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type 16 E5 protein colocalizes with the antiapoptotic Bcl-2 protein.
Auvinen E; Alonso A; Auvinen P
Arch Virol; 2004 Sep; 149(9):1745-59. PubMed ID: 15593417
[TBL] [Abstract][Full Text] [Related]
39. [Human papillomavirus 16 E5 protein inhibits keratinocyte growth factor-triggered autophagy].
Fu G; Gong D; Wan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1517-1521. PubMed ID: 27774947
[TBL] [Abstract][Full Text] [Related]
40. Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.
Krawczyk E; Suprynowicz FA; Sudarshan SR; Schlegel R
J Virol; 2010 Feb; 84(4):1696-703. PubMed ID: 19955310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
